Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, SOLUTION
INTRAVENOUS
Medical Information
V03AB35
sugammadex
Manufacturer Information
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
PLIVA Croatia Ltd.
Active Ingredients
Documents
Package Inserts
Sugammadex Teva Solution for Injection PI.pdf
Approved: February 26, 2024